Burgdorf – Ypsomed's Annual General Meeting on 29 June 2022 approved all the proposals of the Board of Directors. It elected Gilbert Achermann as the new Chairman of the Board of Directors and Simon Michel as a new member of the Board of Directors. The founder and long-standing Chairman Dr. h.c. Willy Michel was given a ceremonial farewell.
At the General Meeting of Shareholders on 29 June 2022, the shareholders of Ypsomed Holding AG approved all proposals.
The previous members of the Board of Directors, Gilbert Achermann, Paul Fonteyne, Dr Martin Münchbach and Betül Susamis Unaran were re-elected. The General Assembly approved the election of Gilbert Achermann as a new Chairman of the Board of Directors.
With full conviction, I have come to the conclusion that now is the best time to pass on the baton. I am also convinced that Gilbert Achermann, with his profound know-how and experience in international medical technology, will help Ypsomed as Chairman to achieve our ambitious growth targets,
comments Dr. h.c. Willy Michel on the changes in the Board of Directors. Dr. h.c. Willy Michel was given a ceremonial farewell by the shareholders with applause. Simon Michel was newly elected to the Board of Directors.
The Annual General Meeting approved a dividend distribution of CHF 8.2 million. Shareholders will receive CHF 0.60 per registered share for the 2021/22 financial year (previous year: CHF 1.16); CHF 0.30 from reserves from capital contributions and CHF 0.30 from retained earnings. The increased dividend in the previous year took into account a compensation payment received as a result of a settlement of a legal dispute.
After an interruption of two years, the General Meeting of Shareholders of Ypsomed Holding AG was again held physically and took place with a special supporting programme. Numerous shareholders and guests of honour of Ypsomed Holding AG attended in person.